SKIN X
Mark Identification

SKIN X

Serial Number

87838002

Filing Date

Mar 16, 2018

Registration Date

Feb 18, 2020

Trademark by

CELLINK BIOPRINTING AB

Active Trademark

Classification Information

Biologically compatible polymers, namely, hydrogels used to manufacture polymeric networks used in the manufacture of engineered living tissue for medical, scientific and non-scientific purposes; Media for cell culture for use in the biotechnological industry; Media for cell culture for use in non-medical research laboratories; Biological preparation for use in cell cultures other than for medical or veterinary use; Engineered biological tissues and tissue arrays, namely, human and animal organ, connective, epithelial, muscular, and nervous tissues and tissue arrays, for use in scientific and medical research; Biologically compatible materials, namely, hydrogels used to create polymeric networks used in the manufacture of living tissue; Proteins in raw material form for scientific and medical research

Chemicals

Pharmaceutical preparations for use in the field of 3D bio-printing of tissues and organs; Pharmaceutical preparations based on cellulous nano-fibrils for use in the 3D bio-printing of tissues and organs; Tissue-regenerative pharmaceutical preparations; Cells for medical use; Human allograft tissue; Living cells for medical use; Implants of living tissues for guided tissue regeneration; Implants comprising living tissue; Implantable materials of living tissue for use in guided tissue regeneration; Skin grafts; Surgical implants comprised of living tissues; Surgical implants of living tissues grown from stem cells; Transdermal patches for use to create skin for prosthetic limbs and for skin grafts; Living tissues for transplant; Engineered biological tissues and organs, namely, human and animal cardiovascular, pulmonary, digestive, hepatobiliary, urological, renal, endocrine, connective, epithelial, muscular, and nervous tissue and organs, for medical purposes; Biological molecules to assist in the development of tissue; Haemostatic gel matrix preparations for treating wounds; Natural biomaterials for augmentation of bone, blood and tissue for medical purposes; Pharmaceutical products for tissue regeneration, for tissue repair, for tissue treatment, whether relating to human or animal tissue; Pharmaceutical preparations for the treatment of bone diseases, for cartilaginous diseases, for vascular diseases, for neuronal degeneration, for degeneration of tendons and ligaments, for retinal degeneration, for renal degeneration, degeneration of soft tissue, for diseases with abnormal cell proliferation; Natural biomaterials for bone filling; Natural biomaterials for filling cartilage; Biological tissue cultures for medical use; Biological tissue cultures for medical purposes; Biological tissue grafts; Biological bone and skin tissues impregnated with lines of oxygen for tissue engineering applications to increase cell survival in tissue intended for subsequent implantation; Gene therapy products, namely, genetically engineered tissues for transplant purposes; Implantable scaffolds comprising living tissue for maintaining tissue contour; Natural biomaterials for augmentation of bone and tissue for medical purposes

Pharmaceuticals